Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Randomized Experiments01:13

Randomized Experiments

7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.2K
Crossover Experiments01:16

Crossover Experiments

3.0K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.0K
Study Design in Statistics01:15

Study Design in Statistics

8.5K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study.

Human reproduction (Oxford, England)·2020
Same author

Predictors of Length of Stay After Vaginal Hysterectomy.

Journal of minimally invasive gynecology·2016
Same author

How often are late preterm births the result of non-evidence based practices: analysis from a retrospective cohort study at two tertiary referral centres in a nationalised healthcare system.

BJOG : an international journal of obstetrics and gynaecology·2013
Same author

Opsoclonus as a manifestation of Hashimoto's encephalopathy.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2012
Same author

Flexible bronchoscopic removal of a three piece foreign body from a child's bronchus.

The Australasian medical journal·2012
Same author

How to achieve balloon stability in aortic valvuloplasty using rapid ventricular pacing.

Images in paediatric cardiology·2012

Related Experiment Video

Updated: Sep 11, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K

Adaptive Design with Bayesian Informed Interim Decisions: Application To a Randomized Trial of Mechanical Circulatory

R Mukherjee1, N Muehlemann2, Y Gao3

  • 1MuSigmas Consultants, Barcelona, Spain.

Therapeutic Innovation & Regulatory Science
|August 16, 2025
PubMed
Summary

This study introduces an adaptive trial design using Bayesian Predictive Power to adjust sample size and follow-up duration for time-to-event endpoints, improving efficiency in cardiovascular and oncology trials.

More Related Videos

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.4K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

22.1K

Related Experiment Videos

Last Updated: Sep 11, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.5K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.4K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

22.1K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Cardiovascular Research
  • Oncology Research

Background:

  • Cardiovascular and oncology trials often require large sample sizes and extended follow-up periods.
  • Traditional methods for time-to-event endpoints rely on proportional hazards assumptions, which may not always be valid.
  • Adaptive trial designs offer optimization through sample size re-estimation, such as the promising zone approach.

Purpose of the Study:

  • To propose and evaluate an adaptive clinical trial design utilizing Bayesian Predictive Power (PP).
  • To guide adjustments in sample size and/or minimum follow-up duration based on interim data.
  • To enhance robustness and efficiency in clinical trials with time-to-event endpoints.

Main Methods:

  • The PROTECT IV trial uses an adaptive design for high-risk percutaneous coronary intervention, initially enrolling 1252 patients with a 12-month follow-up.
  • Interim analyses will employ simulations to determine adaptive increases in sample size (up to 2500) and/or follow-up (up to 36 months) to achieve at least 90% PP.
  • Bayesian Piece-wise Constant Hazard Models are fitted to interim data, avoiding proportional hazards assumptions for more reliable decision-making.

Main Results:

  • Simulations examined the design's utility in scenarios with delayed treatment effects, early benefits, or crossing survival curves.
  • Bayesian modeling, using posterior predictive distributions, facilitates robust interim decision-making.
  • The proposed Bayesian approach demonstrated more specific adaptation rules compared to frequentist Conditional Power, with similar operating characteristics.

Conclusions:

  • Flexible modeling and utilization of patient-level data, like calculating PP, offer a more robust and efficient approach for interim decisions in adaptive trials.
  • This method is particularly beneficial for trials with time-to-event endpoints where survival curve crossing is anticipated.
  • The proposed Bayesian adaptive design enhances decision-making for sample size adjustments compared to traditional methods relying on proportional hazards assumptions.